ATLANTA, July 2 (UPI) -- Routine vaccination of U.S. children for hepatitis has almost doubled since 2006, federal health officials said Thursday.
HONG KONG, June 5 (UPI) -- Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes and are more likely to develop severe hepatitis, says a Chinese study.
VANCOUVER, British Columbia, Nov. 3 (UPI) -- Drug users who contract hepatitis C but fight off infection seem to be shielded from future infections of the liver-killing virus, a Canadian study showed.
KENILWORTH, N.J., Jan. 30 (UPI) -- Schering-Plough said Monday the Food and Drug Administration granted fast track status to its potential hepatitis drug.
LOS ANGELES, Oct. 3 (UPI) -- University of Los Angeles research suggests a Hepatitis C drug is cost-effective in helping patients with treatment-induced anemia.
GHENT, Belgium, Sept. 1 (UPI) -- A new player in the battle against hepatitis prevents inflammation and the death of liver cells, Belgium researchers say.
PROVIDENCE, R.I., July 7 (UPI) -- Inmates entering prisons in Rhode Island had higher rates of HIV and hepatitis than found in the general U.S. population, a Brown University report said.
NEW YORK, April 9 (UPI) -- U.S. researchers reported people who inject illegal drugs are 50 times more likely to contract hepatitis C than those who inhale the substances.
BOSTON, Feb. 12 (UPI) -- A long-acting type of interferon used for hepatitis C appears to be a potent treatment for early HIV infection, researchers in Boston said Wednesday. Six months of treatment with PegIntron cut virus activity by more than 800 percent while boosting the imm
BALTIMORE, April 25 (UPI) -- People who have recovered from infection with the hepatitis C virus may have developed some immunity to future infections, according to a study to be published in Friday's issue of The Lancet. The results may pave the way for development of a vaccine to p
